IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
LEARN MORE
IJPC on Facebook
 
Sign On
  • Home
  • About
    • The Journal
    • Editor-In-Chief
    • Editorial Calendar
    • Submissions
    • Advertising
    • Permissions & Reprints
    • Privacy Policy
  • Subscriptions
    • Subscribe
    • Renew
    • Prices
    • Free Sample
  • Store
    • View Shopping Cart
    • Back Issues
    • Articles
    • Library Archives
    • Compounding Theme Archives
    • Other Products
  • Resources
    • Supplemental Content and Errata
    • Training and Education
    • IJPC-PCAB SOP Matrix
    • USP GAP Analysis
    • Compounders' Network List
    • Patient Information
    • Videos
    • Compounders' Resource Directory
  • Account
  • Contact US

Library CD
Volume 8, 2004 CD
Six back issues from 2004 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.
Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 8 No. 1 January/February 2004 Androgen Deficiency in Women
Vol. 8 No. 2 March/April 2004 Overview of USP Chapter <797>
Vol. 8 No. 3 May/June 2004 Andropause
Vol. 8 No. 4 July/August 2004 Wound Care
Vol. 8 No. 5 September/October 2004 Topical Treatments in Wound Healing
Vol. 8 No. 6 November/December 2004 Endotoxin

Volume 8, 2004 CD ARTICLES

Volume 8, 2004 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor Vol. 8 No. 1 2
Book & Literature Reviews Vol. 8 No. 1 4
Women's Oral Health: Is There a Hormonal Link? Vol. 8 No. 1 10
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Vol. 8 No. 1 16
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP Vol. 8 No. 1 22
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach Vol. 8 No. 1 31
Developing and Providing Compounding Services for Hospitals Involved in a Merger Vol. 8 No. 1 36
American Pharmaceutical Patents From a Historical Perspective Vol. 8 No. 1 40
Basics of Compounding for Disorders of the External Ear Vol. 8 No. 1 46
Urea and Hydrogen Peroxide Otic Solution Vol. 8 No. 1 47
Boric Acid 2% in Isopropyl Alcohol Vol. 8 No. 1 47
Aluminum Acetate Otic Solution Vol. 8 No. 1 47
Hydrocortisone and Acetic Acid Otic Solution Vol. 8 No. 1 47
Acetic Acid and Glycerin Otic Solution Vol. 8 No. 1 47
Ciprofloxacin 1% Otic Drops Vol. 8 No. 1 47
Gentamicin Sulfate 0.1% Otic Solution Vol. 8 No. 1 47
Lidocaine HCl 0.5% Otic Solution Vol. 8 No. 1 47
Neomycin Sulfate 0.5%, Polymyxin B Sulfate 10,000-U/mL and Hydrocortisone 1% Otic Solution Vol. 8 No. 1 47
Nystatin 100,000-units/mL Otic Suspension Vol. 8 No. 1 47
Triamcinolone 0.1% Otic Solution Vol. 8 No. 1 47
Handling of Syringes and Needles Vol. 8 No. 1 49
Calculations Vol. 8 No. 1 50
Aminopyridine 5-mg Capsules Vol. 8 No. 1 51
Boric Acid 600-mg Vaginal Suppository Vol. 8 No. 1 52
Diaminopyridine 10-mg Capsules Vol. 8 No. 1 53
Glycerin 50% Injection Vol. 8 No. 1 54
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Hydrocortisone 2-mg/mL Oral Liquid Vol. 8 No. 1 56
Phenol 5%-in-Oil Injection Vol. 8 No. 1 57
Scopolamine Hydrobromide 0.2% Nasal Spray Vol. 8 No. 1 58
Selegiline HCl 10-mg/mL in Pluronic Lecithin Organogel Vol. 8 No. 1 59
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Quality-Control Analytical Methods: Selecting an Analytical Method Vol. 8 No. 1 61
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy Vol. 8 No. 1 65
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Scientific and Professional Reviewers for 2002/2003 Vol. 8 No. 1 77
PostScription: The Wedgewood Case: What It Means for Pharmacies Vol. 8 No. 1 79
Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor Vol. 8 No. 2 82
Literature Reviews Vol. 8 No. 2 84
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Vol. 8 No. 2 89
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Vol. 8 No. 2 96
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Vol. 8 No. 2 101
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. Vol. 8 No. 2 107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation Vol. 8 No. 2 113
Financially Speaking: Business Continuation Planning Vol. 8 No. 2 120
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Vol. 8 No. 2 123
Basics of Compounding for the Treatment of Warts Vol. 8 No. 2 126
Acyclovir 5% Ointment Vol. 8 No. 2 127
Acyclovir Vaginal Suppository Vol. 8 No. 2 127
Cimetidine 10% and Deoxy-D-Glucose 0.25% Cream Vol. 8 No. 2 127
Lactic Acid 10% and Salicylic Acid 15% in Flexible Collodion Vol. 8 No. 2 127
Podophyllum Resim 25% in Compound Benzoin Tincture Vol. 8 No. 2 127
Podophyllum Resin 20% Ointment Vol. 8 No. 2 127
Podophyllum 20% Gel Vol. 8 No. 2 127
Salicylic Acid 40% Ointment Vol. 8 No. 2 127
Squaric Acid Dibutyl Ester 1% Solution Vol. 8 No. 2 127
Trichloroacetic Acid 20% Topical Solution Vol. 8 No. 2 127
Calibration/Validation of Incubator Temperature Vol. 8 No. 2 130
Calculations Vol. 8 No. 2 132
Dexamethasone 0.04% Topical Spray Vol. 8 No. 2 133
Flucytosine 10-mg/mL Oral Liquid Vol. 8 No. 2 134
Griseofulvin 25-mg/mL Oral Liquid Vol. 8 No. 2 135
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Vol. 8 No. 2 136
Miconazole 10-mg Troches Vol. 8 No. 2 137
Netilmicin 0.455% Ophthalmic Solution Vol. 8 No. 2 138
Pyridoxine HCl 100-mg/mL Injection, Preservative Free Vol. 8 No. 2 139
Stomatitis Mouthwash Vol. 8 No. 2 140
Tacrolimus 0.5-mg/mL Oral Liquid Vol. 8 No. 2 141
Tiagabine 1-mg/mL Oral Liquid Vol. 8 No. 2 142
Quality-Control Analytical Methods: Osmolality and Osmometry Vol. 8 No. 2 143
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Vol. 8 No. 2 147
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor Vol. 8 No. 3 162
Book and Literature Reviews Vol. 8 No. 3 164
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Vol. 8 No. 3 169
Andropause: New Perspectives Vol. 8 No. 3 175
Compounding in the Pharmacy Curriculum: Beyond the Basics Vol. 8 No. 3 181
Migraine Headache Suppositories Vol. 8 No. 3 184
Nitrofurantoin Uretheral Inserts Vol. 8 No. 3 184
Acyclovir Lip Balm Vol. 8 No. 3 184
Gag Tablet Lollipops Vol. 8 No. 3 184
Atropine 1-mg Gelatin Troches Vol. 8 No. 3 184
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs Vol. 8 No. 3 184
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches Vol. 8 No. 3 184
Amphotericin B 2-mg/mL Ophthalmic Solution Vol. 8 No. 3 185
Morphine Sulfate 5-mg/0.1-mL Nasal Spray Vol. 8 No. 3 185
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops Vol. 8 No. 3 185
Nifedipine 20% Vasodilating Gel Vol. 8 No. 3 185
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Vol. 8 No. 3 185
Estrogen 0.625-mg/5-g Vaginal Gel Vol. 8 No. 3 185
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Vol. 8 No. 3 185
Pain Management in the Elderly Vol. 8 No. 3 187
Precepting: A Win-Win Situation for All Vol. 8 No. 3 194
A Foot in the Door: Building Relationships Builds Your Business Vol. 8 No. 3 197
Automatic Dishwashers and Detergents in the Pharmacy: The Basics Vol. 8 No. 3 200
Pharmaceutical Compounding Calculations Vol. 8 No. 3 203
Basics of Compounding for Cold Sores or Fever Blisters Vol. 8 No. 3 206
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) Vol. 8 No. 3 208
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) Vol. 8 No. 3 208
Emollient Lip Balm with 5% Benzocaine Vol. 8 No. 3 208
Fever Blister Ointment Vol. 8 No. 3 208
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream Vol. 8 No. 3 208
Lemon Balm 1% Cream Vol. 8 No. 3 209
Acyclovir 5% and Lidocaine HCl 2% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel Vol. 8 No. 3 209
Foscarnet 3% and Sodium Lauryl Sulfate 5% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Dexamethasone 0.1% Topical Gel Vol. 8 No. 3 209
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel Vol. 8 No. 3 209
Standard Operating Procedure: Disposal of Chemicals Vol. 8 No. 3 210
Calculations Vol. 8 No. 3 211
Alpha Hydroxy Acids Lotion Vol. 8 No. 3 213
Amiodarone HCl 5-mg/mL Oral Liquid Vol. 8 No. 3 214
Atenolol 2-mg/mL Oral Liquid Vol. 8 No. 3 215
Clonidine HCl 1.5-mg/mL Injection Vol. 8 No. 3 216
Fluorouracil 1% Ophthalmic Solution Vol. 8 No. 3 217
Glycopyrrolate 0.5-mg/mL Oral Liquid Vol. 8 No. 3 218
Ketoprofen 50-mg Suppository Vol. 8 No. 3 219
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Vol. 8 No. 3 220
Sumatriptan 25-mg Suppository Vol. 8 No. 3 221
Testosterone Propionate 100-mg/mL in Oil Injection Vol. 8 No. 3 222
Quality-Control Analytical Methods: High-Performance Liquid Chromatography Vol. 8 No. 3 223
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
PostScription: How should a pharmacist be trained? Vol. 8 No. 3 240
PreScription - Categories of Pharmaceutial Compounding Vol. 8 No. 4 242
Book and Literature Reviews Vol. 8 No. 4 244
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Case Report: Wound Care of a Diabetic Foot Ulcer Vol. 8 No. 4 265
Case Reports: Their Impact Vol. 8 No. 4 266
Current Topical Treatments in Wound Healing - Part 1 Vol. 8 No. 4 269
Warts: Facts and Therapy (Patient Handout) Vol. 8 No. 4 275
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Vol. 8 No. 4 277
Rationale for a Pharmacists' Pharmacopeia Vol. 8 No. 4 285
Basics of Compounding for Fungal Sinusitis Vol. 8 No. 4 289
Amphotericin 100-mcg/mL Nasal Irrigation/Spray Vol. 8 No. 4 290
Ketoconazole 1% Nasal Irrigation/Spray Vol. 8 No. 4 290
Miconazole 1% Nasal Irrigation/Spray Vol. 8 No. 4 290
Nystatin 50,000-Units/mL Nasal Irrigation Vol. 8 No. 4 290
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Vol. 8 No. 4 292
Calculations Vol. 8 No. 4 294
Diltiazem 2% in Pluronic Lecithin Organogel Vol. 8 No. 4 295
Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse Vol. 8 No. 4 296
Estradiol 0.01% Wound Gel Vol. 8 No. 4 297
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder Vol. 8 No. 4 298
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel Vol. 8 No. 4 299
Metronidazole 2% Topical Gel Vol. 8 No. 4 300
Pentoxifylline 5% Topical Cream Vol. 8 No. 4 301
Tretinoin 0.1% and Lidocaine HCl 0.5% Topical Gel Vol. 8 No. 4 302
Veterinary Wound Dressing Vol. 8 No. 4 303
Wound Cleansing Spray Vol. 8 No. 4 304
Quality-Control Analytical Methods: Gas Chromatography Vol. 8 No. 4 305
Enhanced Release of Diazepam from Hollow-Type Suppositories Vol. 8 No. 4 310
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vol. 8 No. 4 313
PostScription: What is Evidence-Based Medicine? Vol. 8 No. 4 320
Prescription: Accreditation of Pharmacies and Certification of Pharmacists Vol. 8 No. 5 322
Book and Literature Reviews Vol. 8 No. 5 324
Domperidone in Lactation: Use as a Galactagogue Vol. 8 No. 5 329
Domperidone Capsules 10-, 20- and 30-mg Vol. 8 No. 5 332
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications Vol. 8 No. 5 337
Head to Toe Solutions: A Quick Review of Current Therapies Vol. 8 No. 5 345
Aromatic Head Lice Oil Vol. 8 No. 5 346
Current Topical Treatments in Wound Healing - Part 2 Vol. 8 No. 5 354
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Vol. 8 No. 5 359
Wish You Were Here: American Institute of the History of Pharmacy, Madison, Wisconsin Vol. 8 No. 5 368
A Foot in the Door: Marketing Tips - Dealing With Personalities Vol. 8 No. 5 373
Basics of Compounding for Skin Discolorations Vol. 8 No. 5 376
Hydroquinone 5% Cream Vol. 8 No. 5 378
Hydroquinone 5% in Isopropyl Alcohol Vol. 8 No. 5 378
Hydroquinone 5% Topical Gel Vol. 8 No. 5 378
Hydroquinone 5% Topical Stick, Water Repellant Vol. 8 No. 5 378
Hydroquinone 5% Topical Stick, Water Soluble Vol. 8 No. 5 378
Dexamethasone 0.1%, Hydroquinone 5% and Retinoic Acid 0.1% Ointment Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Gel Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Cream Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Ointment Vol. 8 No. 5 379
Hydrocortisone 1%, Hydroquinonne 5% and Glycolic Acid 5% Lotion Vol. 8 No. 5 379
Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records Vol. 8 No. 5 381
Calculations Vol. 8 No. 5 382
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Vol. 8 No. 5 383
Benzalkonium Chloride 0.1% Topical Gel Vol. 8 No. 5 384
Camphor 0.3%, Menthol 0.3% and Phenol 0.3% Topical Gel Vol. 8 No. 5 385
Coal Tar 1% Topical Gel Vol. 8 No. 5 386
Diclofenac Sodium 1.5% Topical Gel Vol. 8 No. 5 387
Ibuprofen 2% Topical Gel Vol. 8 No. 5 388
Ketamine HCl 5% and Ketoprofen 5% in PLO Vol. 8 No. 5 389
Ketoprofen 5% and Loperamide 7.5% in PLO Vol. 8 No. 5 390
Resorcinol 1% and Salicylic Acid 3% Gel Vol. 8 No. 5 391
Salicylic Acid 6% Topical Gel Vol. 8 No. 5 392
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Vol. 8 No. 5 393
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
PostScription: Your voice is important to the future of pharmacy Vol. 8 No. 5 407
PreScription: US Pharmacopeia-US Dispensatory: Pharmacist's Edition Vol. 8 No. 6 410
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle Vol. 8 No. 6 412
Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't Vol. 8 No. 6 412
Literature Reviews Vol. 8 No. 6 413
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Vol. 8 No. 6 419
The Salivary Hormone Profile in the Clinical Evaluation of Women Vol. 8 No. 6 427
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Vol. 8 No. 6 436
Compounding for Sports Medicine Vol. 8 No. 6 443
Is Veterinary Compounding Illegal Under Federal Law? Vol. 8 No. 6 449
Cleaning of Isolators: A Vital Part of a Contamination Control Program Vol. 8 No. 6 452
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Vol. 8 No. 6 458
Basics of Compounding for Cough Vol. 8 No. 6 462
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Vol. 8 No. 6 466
Calculations Vol. 8 No. 6 468
BAD (Benadryl, Ativan, and Decadron) Intravenous Drip Vol. 8 No. 6 469
Diclofenac Sodium 25-mg/mL Injection Vol. 8 No. 6 470
Gentamicin Sulfate, Neomycin Sulfate, and Polymixin B Sulfate Bladder Irrigation Vol. 8 No. 6 471
Gentamicin Sulfate 0.2%, Misoprostol 0.0024%, and Phenytoin 5% Topical Gel Vol. 8 No. 6 472
Itraconazole 0.1% Nasal Irrigation Vol. 8 No. 6 473
Ketamine Hydrochloride and Fentanyl Citrate Injection Vol. 8 No. 6 474
Ketamine 25-mg/mL Nasal Spray Vol. 8 No. 6 475
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray Vol. 8 No. 6 476
Ofloxacin 0.5% Topical Liquid Vol. 8 No. 6 477
Sodium Hypochlorite 0.025% Topical Solution Vol. 8 No. 6 478
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Vol. 8 No. 6 479
Stability of Extemporaneous Oral Ribavirin Liquid Preparation Vol. 8 No. 6 486
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Vol. 8 No. 6 489
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Vol. 8 No. 6 492
PostScription Vol. 8 No. 6 496
Home |  About  |  Contact  |  Advertising |  Privacy Policy                                                            ©2019 IJPC, Inc.